Bristol Myers Squibb Expands AI Collaboration with Nvidia
Bristol Myers Squibb has expanded its partnership with Nvidia to enhance its artificial intelligence infrastructure, deploying an advanced computing system designed to improve drug discovery and development. The new platform is expected to support research in multiple therapeutic areas by providing greater computational power.
Topics: AI in drug discovery Nvidia AI infrastructure Pharmaceutical technology partnership